Canaan IX L.P. Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Canaan IX L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Canaan IX L.P.. Canaan IX L.P. is Director in CytomX Therapeutics, Inc. ($CTMX) and 10% Owner in TheRealReal, Inc. ($REAL) and 10% Owner in ARVINAS INC. ($ARVN).
Latest Insider Trading Transactions of Canaan IX L.P.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARVN, CTMX, REAL
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 15 2020 | ARVN | ARVINAS, INC. | Canaan IX L.P. | 10% Owner | Sell | J | 0.00 | 400,000 | 0 | 3,589,554 | 4 M to 3.6 M (-10.03 %) |
Jul 21 2020 | ARVN | ARVINAS, INC. | Canaan IX L.P. | 10% Owner | Sell | J | 0.00 | 500,000 | 0 | 3,989,554 | 4.5 M to 4 M (-11.14 %) |
Jan 16 2020 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Sell | J | 0.00 | 881,000 | 0 | 7,925,919 | 8.8 M to 7.9 M (-10.00 %) |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Option Exercise | C | 0.00 | 427,020 | 0 | 0 | |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Option Exercise | C | 0.00 | 427,020 | 0 | 0 | |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Option Exercise | C | 0.00 | 654,298 | 0 | 0 | |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Option Exercise | C | 0.00 | 654,298 | 0 | 0 | |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,790,580 | 0 | 0 | |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,790,580 | 0 | 0 | |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,120,823 | 0 | 0 | |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,120,823 | 0 | 0 | |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,214,825 | 0 | 0 | |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,214,825 | 0 | 0 | |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,398,272 | 0 | 0 | |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,398,272 | 0 | 0 | |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Buy | C | 0.00 | 213,510 | 0 | 8,806,919 | 8.6 M to 8.8 M (+2.48 %) |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Buy | C | 0.00 | 213,510 | 0 | 8,806,919 | 8.6 M to 8.8 M (+2.48 %) |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Buy | C | 0.00 | 327,149 | 0 | 8,593,409 | 8.3 M to 8.6 M (+3.96 %) |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Buy | C | 0.00 | 327,149 | 0 | 8,593,409 | 8.3 M to 8.6 M (+3.96 %) |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Buy | C | 0.00 | 895,290 | 0 | 8,266,260 | 7.4 M to 8.3 M (+12.15 %) |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Buy | C | 0.00 | 895,290 | 0 | 8,266,260 | 7.4 M to 8.3 M (+12.15 %) |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Buy | C | 0.00 | 2,060,411 | 0 | 7,370,970 | 5.3 M to 7.4 M (+38.80 %) |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Buy | C | 0.00 | 2,060,411 | 0 | 7,370,970 | 5.3 M to 7.4 M (+38.80 %) |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Buy | C | 0.00 | 1,107,412 | 0 | 5,310,559 | 4.2 M to 5.3 M (+26.35 %) |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Buy | C | 0.00 | 1,107,412 | 0 | 5,310,559 | 4.2 M to 5.3 M (+26.35 %) |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Buy | C | 0.00 | 3,699,136 | 0 | 4,203,147 | 504 K to 4.2 M (+733.94 %) |
Jul 02 2019 | REAL | TheRealReal, Inc. | Canaan IX L.P. | 10% Owner | Buy | C | 0.00 | 3,699,136 | 0 | 4,203,147 | 504 K to 4.2 M (+733.94 %) |
Jun 12 2019 | ARVN | ARVINAS, INC. | Canaan IX L.P. | 10% Owner | Sell | J | 0.00 | 500,000 | 0 | 4,489,554 | 5 M to 4.5 M (-10.02 %) |
Oct 03 2018 | ARVN | ARVINAS INC. | Canaan IX L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,209,833 | 0 | 0 | |
Oct 03 2018 | ARVN | ARVINAS INC. | Canaan IX L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,462,837 | 0 | 0 | |
Oct 03 2018 | ARVN | ARVINAS INC. | Canaan IX L.P. | 10% Owner | Option Exercise | C | 0.00 | 9,543,387 | 0 | 0 | |
Oct 03 2018 | ARVN | ARVINAS INC. | Canaan IX L.P. | 10% Owner | Buy | C | 0.00 | 4,989,554 | 0 | 4,989,554 | 0 to 5 M |
Mar 28 2017 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | J | 0.00 | 750,000 | 0 | 2,494,381 | 3.2 M to 2.5 M (-23.12 %) |
Dec 01 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | J | 0.00 | 400,000 | 0 | 3,244,381 | 3.6 M to 3.2 M (-10.98 %) |
Dec 01 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 11.18 | 22,086 | 247,008 | 3,644,381 | 3.7 M to 3.6 M (-0.60 %) |
Nov 28 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 11.33 | 20,840 | 236,142 | 3,666,467 | 3.7 M to 3.7 M (-0.57 %) |
Nov 28 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 11.79 | 6,729 | 79,341 | 3,687,307 | 3.7 M to 3.7 M (-0.18 %) |
Nov 28 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 11.84 | 10,890 | 128,921 | 3,694,036 | 3.7 M to 3.7 M (-0.29 %) |
Nov 22 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 11.71 | 42,550 | 498,078 | 3,704,926 | 3.7 M to 3.7 M (-1.14 %) |
Nov 21 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 11.72 | 13,548 | 158,785 | 3,747,476 | 3.8 M to 3.7 M (-0.36 %) |
Nov 21 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 11.64 | 12,805 | 149,085 | 3,761,024 | 3.8 M to 3.8 M (-0.34 %) |
Nov 21 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 11.50 | 18,971 | 218,218 | 3,773,829 | 3.8 M to 3.8 M (-0.50 %) |
Nov 16 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 11.55 | 18,517 | 213,953 | 3,792,800 | 3.8 M to 3.8 M (-0.49 %) |
Nov 16 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 11.48 | 33,064 | 379,476 | 3,811,317 | 3.8 M to 3.8 M (-0.86 %) |
Nov 14 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 11.21 | 23,744 | 266,056 | 3,844,381 | 3.9 M to 3.8 M (-0.61 %) |
Nov 14 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 11.20 | 35,391 | 396,461 | 3,868,125 | 3.9 M to 3.9 M (-0.91 %) |
Nov 14 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 11.07 | 27,135 | 300,390 | 3,903,516 | 3.9 M to 3.9 M (-0.69 %) |
Nov 10 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 11.03 | 13,730 | 151,498 | 3,930,651 | 3.9 M to 3.9 M (-0.35 %) |
Oct 12 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | J | 0.00 | 300,000 | 0 | 3,944,381 | 4.2 M to 3.9 M (-7.07 %) |
Jun 10 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.01 | 2,700 | 27,027 | 4,244,381 | 4.2 M to 4.2 M (-0.06 %) |
Jun 10 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.06 | 22,842 | 229,791 | 4,247,081 | 4.3 M to 4.2 M (-0.53 %) |
Jun 10 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.08 | 22,885 | 230,681 | 4,269,923 | 4.3 M to 4.3 M (-0.53 %) |
Jun 08 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.03 | 9,731 | 97,602 | 4,292,808 | 4.3 M to 4.3 M (-0.23 %) |
Jun 08 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.01 | 101,767 | 1,018,688 | 4,302,539 | 4.4 M to 4.3 M (-2.31 %) |
Jun 06 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.83 | 18,428 | 199,575 | 4,404,306 | 4.4 M to 4.4 M (-0.42 %) |
Jun 06 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.79 | 41,193 | 444,472 | 4,422,734 | 4.5 M to 4.4 M (-0.92 %) |
Jun 02 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.75 | 22,463 | 241,477 | 4,463,927 | 4.5 M to 4.5 M (-0.50 %) |
Jun 01 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.60 | 25,082 | 265,869 | 4,486,390 | 4.5 M to 4.5 M (-0.56 %) |
May 27 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.43 | 39,887 | 416,021 | 4,511,472 | 4.6 M to 4.5 M (-0.88 %) |
May 27 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.02 | 11,456 | 114,789 | 4,551,359 | 4.6 M to 4.6 M (-0.25 %) |
May 25 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.00 | 1,200 | 12,000 | 4,562,815 | 4.6 M to 4.6 M (-0.03 %) |
May 25 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.10 | 12,053 | 121,735 | 4,564,015 | 4.6 M to 4.6 M (-0.26 %) |
May 23 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.09 | 6,187 | 62,427 | 4,576,068 | 4.6 M to 4.6 M (-0.14 %) |
May 23 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.14 | 2,500 | 25,350 | 4,582,255 | 4.6 M to 4.6 M (-0.05 %) |
Apr 26 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | J | 0.00 | 300,000 | 0 | 4,584,755 | 4.9 M to 4.6 M (-6.14 %) |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Option Exercise | C | 0.00 | 1,318,418 | 0 | 0 | |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Option Exercise | C | 0.00 | 3,566,337 | 0 | 0 | |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Buy | C | 0.00 | 4,884,755 | 0 | 4,884,755 | 0 to 4.9 M |
Page: 1